Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 192,300.00 KRW | -0.93% |
|
-4.33% | +11.56% |
| Aug. 18 | Celltrion's Acquired French Healthcare Firm Becomes Fully Operational | MT |
| Aug. 04 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| Market Cap | 44,100B 31.82B 27.26B 25.5B 23.35B 43.81B 3,045B 44.39B 301B 118B 1,529B 119B 117B 5,059B | P/E 2026 * |
29.2x | P/E 2027 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise Value | 46.3B 33.41M 28.62M 26.78M 24.51M 46M 3.2B 46.61M 316M 123M 1.61B 125M 123M 5.31B | EV / Sales 2026 * |
8.45x | EV / Sales 2027 * | 7.23x |
| Free-Float |
60.59% | Yield 2026 * |
0.39% | Yield 2027 * | 0.43% |
| 1 day | -0.93% | ||
| 1 week | -4.33% | ||
| Current month | +3.00% | ||
| 1 month | +12.06% | ||
| 3 months | +6.50% | ||
| 6 months | -16.56% | ||
| Current year | +11.56% |
| 1 week | 187,600 |  | 202,000 |
| 1 month | 170,100 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.93% | -4.33% | +17.87% | +51.96% | 31.82B | |
| +1.09% | +5.26% | +4.44% | +26.03% | 51.61B | |
| -1.07% | +2.82% | +474.18% | +601.24% | 44.89B | |
| +1.47% | +9.79% | +40.15% | +21.21% | 42.77B | |
| +1.44% | +7.77% | +19.27% | +90.94% | 42.58B | |
| +1.32% | +7.30% | +36.93% | +152.36% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | |
| +1.28% | +5.41% | +91.01% | +46.93% | 14.09B | |
| -1.17% | +5.57% | -1.97% | -30.78% | 13.29B | |
| Average | +0.29% | +4.55% | +76.55% | +110.60% | 28.98B | |
| Weighted average by Cap. | +0.41% | +4.76% | +97.48% | +139.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 3.95B 3.39B 3.17B 2.9B 5.44B 378B 5.52B 37.45B 14.6B 190B 14.85B 14.53B 629B | 6,294B 4.54B 3.89B 3.64B 3.33B 6.25B 435B 6.34B 43B 16.77B 218B 17.05B 16.68B 722B |
| Net income | 1,511B 1.09B 934M 874M 800M 1.5B 104B 1.52B 10.32B 4.03B 52.4B 4.09B 4B 173B | 1,763B 1.27B 1.09B 1.02B 934M 1.75B 122B 1.78B 12.05B 4.7B 61.16B 4.78B 4.67B 202B |
| Net Debt | 2,199B 1.59B 1.36B 1.27B 1.16B 2.18B 152B 2.21B 15.02B 5.86B 76.25B 5.96B 5.83B 252B | 1,409B 1.02B 871M 815M 746M 1.4B 97.28B 1.42B 9.63B 3.75B 48.87B 3.82B 3.73B 162B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ₩192,300.00 | -0.93% | 354,956 |
| 26-08-20 | ₩194,100.00 | 0.00% | 484,272 |
| 26-08-19 | ₩194,100.00 | -0.72% | 375,772 |
| 26-08-18 | ₩195,500.00 | -2.74% | 600,291 |
| 26-08-14 | ₩201,000.00 | -0.50% | 341,446 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
